id
name
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2023-10-11 19:51:47
expired found date
-
created at
2024-06-30 12:00:07
updated at
2026-01-26 23:05:33
length
10
crc
51671
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
114390
mp size raw text
7911
mp inner links count
0
mp inner links status
20 (imported)
title
Biopharmaceutical Company for Brain Health Disorders - Sage Therapeutics
description
Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs.
image
site name
Sage Therapeutics
author
updated
2026-01-05 20:56:01
raw text
Biopharmaceutical Company for Brain Health Disorders - Sage Therapeutics NOW FDA APPROVED: ZURZUVAE ™ (zuranolone), for the treatment of women with postpartum depression* *Pending scheduling by the U.S. Drug Enforcement Administration LEARN MORE Seeing the brain differently makes a world of difference Learn More About Our Approach Previous Next Previous Next INSIGHTS & POINT OF VIEW Sage Thoughts View More “In Their Words”: Katie and Mike’s journey with Huntington’s disease LEARN MORE At the Crossroads of Innovation and Policy, People Suffer LEARN MORE Brain Works LEARN MORE News The latest from Sage press releases Sage Therapeutics to Present at Upcoming September Investor Conferences events TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit sage thoughts At Sage, we believe we see possibilities wh...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
Medicine [en] (226)
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
4962
text words
848
text unique words
356
text lines
217
text sentences
27
text paragraphs
8
text words per sentence
31
text matched phrases
17
text matched dictionaries
4
links self subdomains
0
links other subdomains
16 - investor.sagerx.com, assets.sagerx.com, careers.sagerx.com, medical.sagerx.com, fundingandgiving.sagerx.com
links other domains
0
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
links ext klim
0
links ext generic
0
dol status
0
dol updated
2026-01-05 20:56:01
rss path
rss status
1 (priority 1 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)
sitemap review version
2
sitemap urls count
59
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-08-22 11:23:43
sitemap process date
2024-08-22 11:23:44
sitemap first import date
-
sitemap last import date
2026-01-26 23:05:33